Approval · Notice of Compliance 8893 · 2007
MIRAPEX: Notice of Compliance 8893
Issued July 6, 2007
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 8893
- Date
- July 6, 2007
- Company
- Boehringer Ingelheim (Canada) Ltd.Burlington, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- New strength: 0.125mg
- Therapeutic class
- Antiparkinsonian agent / dopamine agonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MIRAPEX | 02297256 | Marketed |
Medicinal ingredients
- PRAMIPEXOLE 0.125 MG per TAB